MIMichael S. Ingber

Michael S. Ingber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael S. Ingber has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient Satisfaction With a Novel Postcoital Intravaginal Fluid-Absorbing Device

    by Michael Ingber, Anne L. Ackerman, Rachel Rubin, Ryan Sobel

    OBJECTIVE: To evaluate patient-reported symptom outcomes, usability, and vaginal pH after use of a postcoital intravaginal fluid-absorbing device. METHODS: In this prospective cohort study, adult women who were sexually active with male partners used a postcoital intravaginal fluid-absorbing device after intercourse. Participants completed baseline symptom assessments and a postuse questionnaire evaluating discharge, odor, usability, and likelihood of reuse. A subset performed paired vaginal pH measurements at baseline and at 2–6 and 10–14 hours after intercourse under two conditions: intercourse without the device and intercourse followed by device use. Paired t tests were used for comparisons. RESULTS: A total of 542 participants enrolled; 291 (53.7%) completed the postuse questionnaire. Baseline postcoital symptoms were common, including discharge or dripping (87.6%), vaginal odor (64.9%), and a sensation of feeling unclean (58.1%). Among respondents, 98.0% reported improvement in postcoital discharge and 84.3% reported improvement in vaginal odor after device use. Most participants reported they would use the product again (93.1%) and recommend it to others (94.2%). Usability ratings were favorable, with 88.3% reporting ease of insertion and 93.1% reporting ease of removal. In the paired pH subset (n=48), mean vaginal pH was lower with device use compared with no device at 2–6 hours (5.2±0.9 vs 5.5±0.9, P =.025) and at 10–14 hours (4.6±0.6 vs 5.1±0.8, P <.001). CONCLUSION: Use of a postcoital intravaginal fluid-absorbing device was associated with improvement in patient-reported postcoital discharge and odor, high user acceptability, and lower vaginal pH after intercourse. These findings support further evaluation of nonpharmacologic approaches to managing common postcoital gynecologic symptoms. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT06530186.

  • Vesicovaginal and Urethrovaginal Fistula Repair

    by Michael Ingber, Raymond R. Rackley

  • Laparoendoscopic single-site (LESS) hysteropexy

    by Michael S. Ingber, Marc D. Colton, Gregg E. Zimmerman

    Uterine prolapse is one of the common reasons for hysterectomy throughout the world. However, recent data has shown that uterine-sparing techniques appear to be equivocal to that of hysterectomy. Older reports of intra-abdominal uterine suspension describe open approaches and more recent descriptions involve robotic and laparoscopic approaches utilizing mesh. We describe the first reported laparoendoscopic single-site (LESS) sacral hysteropexy utilizing a strip of polypropylene mesh placed posteriorly on the uterus and attached to the sacral promontory. A 45-year-old female with grade 3 uterine prolapse, cystocele, and rectocele underwent the procedure. The procedure involved access utilizing a single-port system placed transumbilically, and dissection using articulating laparoscopic instruments. The hysteropexy was completed by placing a 3-cm wide strip of polypropylene mesh along the posterior vaginal wall and cervicouterine junction, and suturing the proximal end to the anterior longitudinal ligament overlying the sacral promontory. The patient was discharged home within 18 h of the procedure. At 6 month follow-up, the patient has excellent anatomic support, with no evidence for recurrence of prolapse. LESS hysteropexy appears to be a safe, effective procedure for uterine prolapse and provides patients with excellent outcome with no visible scar. Additional studies will determine whether the LESS approach provides any benefit when compared with robotic or traditional laparoscopic approaches with respect to blood loss, pain, and time of full recovery.


  • Reply by the Authors

    by Michael S. Ingber, Sandip P. Vasavdada, Farzeen Firoozi, Howard B. Goldman

  • Force of Stream After Sling Therapy: Safety and Efficacy of Rapid Discharge Care Pathway Based on Subjective Patient Report

    by Michael S. Ingber, Sandip P. Vasavada, Courtenay K. Moore, Raymond R. Rackley, Farzeen Firoozi, Howard B. Goldman

    We evaluated the safety of a mid urethral sling postoperative care pathway using patient subjective reporting of force of stream to minimize length of stay and catheter placement. Women undergoing solitary mid urethral sling surgery were prospectively enrolled in our study. Force of stream after the sling therapy protocol consisted of retrograde bladder filling with 300 ml fluid within 1 hour after surgery. Patients rated force of stream compared to baseline on a visual analog scale. Those with a force of stream of 50% or greater were immediately discharged home regardless of post-void residual urine volume. Only those unable to void and those rating force of stream less than 50% with post-void residual urine volume greater than 500 ml were discharged home with a catheter. Patients were telephoned within 1 week of surgery and seen 4 to 6 weeks postoperatively. The primary outcome was unexpected visits to the emergency room or office for voiding dysfunction or urinary retention. A total of 114 women were prospectively enrolled in our study, of whom 105 (92.1%) passed the protocol and were discharged home without a catheter. Of the patients 14 were discharged home with increased post-void residual urine volume (range 152 to 427 ml) but no catheter, representing those who would have been discharged with a catheter by many traditional voiding protocols. According to protocol 9 patients were discharged with a catheter. No patient presented to the emergency room or office in urinary retention or with voiding dysfunction before the scheduled visit. Patients who report a force of stream of 50% or greater can be safely and rapidly discharged home after an uncomplicated mid urethral sling procedure regardless of post-void residual urine volume. Scanned post-void residual urine volume does not add much value in those who can void. By following the force of stream after sling therapy protocol patients can be discharged home less than 3 hours after mid urethral sling surgery.


  • Surgically Corrected Urethral Diverticula: Long-term Voiding Dysfunction and Reoperation Rates

    by Michael S. Ingber, Farzeen Firoozi, Sandip P. Vasavada, Christina B. Ching, Howard B. Goldman, Courtenay K. Moore, Raymond R. Rackley


  • Incidence of Perioperative Urinary Tract Infection After Single-dose Antibiotic Therapy for Midurethal Slings

    by Michael S. Ingber, Sandip P. Vasavada, Farzeen Firoozi, Howard B. Goldman